3.1334
1.77%
-0.0566
시간 외 거래:
3.13
-0.0034
-0.11%
Neuraxis Inc 주식(NRXS)의 최신 뉴스
Critical Review: BioSig Technologies (NASDAQ:BSGM) vs. NeurAxis (NASDAQ:NRXS) - Defense World
NeurAxis, Inc. (NASDAQ:NRXS) Q3 2024 Earnings Call Transcript - MSN
Neuraxis secures $5 million in preferred stock sale By Investing.com - Investing.com Canada
Neuraxis secures $5 million in preferred stock sale - Investing.com
Neuronetics Grants Inducement Awards to New Employees - MSN
NeurAxis Stock Surges After Strong Q3 Earnings And Expanded Coverage - Barchart
NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage - Yahoo Finance
NeurAxis reports 40% increase in revenues in Q3 2024 - Medical Buyer
NeurAxis Reports Strong Revenue Growth in Q3 2024 - TipRanks
Neuraxis Inc. (NRXS) Quarterly 10-Q Report - Quartzy
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues - GlobeNewswire
NeurAxis Q3 Revenue Surges 40%, Expands Coverage to 35M Lives Amid FDA Milestone | NRXS Stock News - StockTitan
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market - Building Indiana
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024 - GlobeNewswire
NeurAxis (NRXS) Sets Q3 2024 Earnings Call for November 12 | Neuromodulation Leader | NRXS Stock News - StockTitan
IRIDEX (NASDAQ:IRIX) versus NeurAxis (NASDAQ:NRXS) Financial Survey - Defense World
NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024 - The Manila Times
NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - GlobeNewswire
Neuraxis adjusts equity agreement, secures additional funding - Investing.com India
Creatd (NASDAQ:VOCL) Stock Price Down 4.4% – Should You Sell? - Defense World
Technip Energies (OTCMKTS:THNPY) Trading Up 0.7% – Here’s What Happened - Defense World
Vestas Wind Systems A/S (OTCMKTS:VWSYF) Shares Up 1.2% – Here’s What Happened - Defense World
Zacks Initiates Coverage of NeurAxis With Neutral Recommendation - Yahoo Finance
The Zacks Analyst Blog Highlights Costco Wholesale, Alibaba, GE Aerospace, Applied Energetics and NeurAxis - Yahoo Finance
Top Analyst Reports for Costco Wholesale, Alibaba & GE Aerospace - Yahoo Finance
NeurAxis (NASDAQ:NRXS) Trading Up 6% - Defense World
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - GlobeNewswire
Neuraxis issues shares in equity financing By Investing.com - Investing.com Australia
Neuraxis issues shares in equity financing - Investing.com
Fishers startup prepares to go public - Greenfield Daily Reporter
NeurAxis (NASDAQ:NRXS) Stock Price Down 2.2% - Defense World
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 - GlobeNewswire
Vagus Nerve Stimulators Market Projected to Witness Huge Growth - openPR
Neuraxis shareholders approve key proposals at annual meeting - Investing.com
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 - GlobeNewswire
NeurAxis revenue down 5.3% to USD 611.5K in Q2 2024 - Medical Buyer
NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript - Seeking Alpha
Contrasting Sonova (OTCMKTS:SONVY) & NeurAxis (NASDAQ:NRXS) - Defense World
NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024 - MSN
NeurAxis Reports Second Quarter 2024 Financial Results - GlobeNewswire
NeurAxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Vagus Nerve Stimulators Market Is Booming Worldwide 2024-2031 | - openPR
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024 - GlobeNewswire
자본화:
|
볼륨(24시간):